1. Academic Validation
  2. Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin

Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin

  • Biochem Biophys Res Commun. 2006 Sep 29;348(3):807-13. doi: 10.1016/j.bbrc.2006.07.169.
Yukihiro Hama 1 Yasuteru Urano Yoshinori Koyama Peter L Choyke Hisataka Kobayashi
Affiliations

Affiliation

  • 1 Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892-1088, USA.
Abstract

Lectins (asialo-receptor family) are expressed on a number of tumors that develop peritoneal metastases. To demonstrate that fluorescence imaging based on lectin binding is applicable for a variety of tumors, we conjugated BODIPY to avidin (avidin-BODIPY), and studied the efficacy of tumor targeting in 9 Cancer cell lines in vitro and an ovarian Cancer cell line in vivo using a murine peritoneal Cancer model. All 9 cell lines showed specific intracellular accumulation with avidin-BODIPY on fluorescence microscopy and flow cytometry. In vivo spectral molecular imaging clearly visualized the peritoneal tumor foci with avidin-BODIPY, whereas, deglycosylated avidin-BODIPY (neutravidin-BODIPY) showed only minimal fluorescence from the tumor foci and was accompanied by higher background signals. These results suggest the lectin-targeted molecular imaging technique using a targeted green fluorescence probe is potentially useful in a wide variety of cancers with a proclivity for dissemination in the peritoneal space.

Figures
Products